Search
/sustainability/esg-social
Social, Social banner v7.png, Sustainability
,
.h2-social-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
padding-top: 1em;
}
.h3-s
,
employee engagement statistics.png
,
Health and safetyHealth and safety management is an essential part of ALK’s operations, especially in production and farming activities where employee
,
.image-container-single-image {
display: flex;
justify-content: center;
align-items: center;
height: 100%;
width: 100%;
}
.
,
1 2022 and 2023 figures are not covered by the Independent Auditor’s limited assurance report on the Sustainability Statement
,
Regular safety dialogues with workers councils or employees, Monthly safety inspections across all production facilities, Digitalisation of near miss frequency reporting
,
Non-discrimination/inclusionEmbracing a multi-dimensional perspective, we acknowledge diversity in terms of physical, psychological, social, lifestyle
,
non-discrimination-graph.png
,
Third party code of conductRead more in diversity and inclusion policy
,
.text-image-container {
display: flex;
flex-direction: row;
align-items: center;
justify-content:
,
Value chain workersALK's Third-party Code of Conduct outlines the standards of behavior that we expect from all third parties globally when it comes t
,
Consumers and end users
,
.image-container-single-image-2 {
display: flex;
justify-content: center;
align-items: center;
height: 100%;
width: 100%;
,
Left, Social inclusion of consumers and end-usersWith over 500 million people worldwide affected by respiratory allergies, many suffer without adequate supp, Screenshot 2024-02-02 at 17.00.40.png
,
Safety of people with allergiesALK has a rigorous safety reporting system in place ensuring that safety data from any source, including clinical trial
,
Education of healthcare professionalsWe engage systematically in educational activities, training and dialogue with healthcare professionals to elevat
,
Policy downloads
,
Code of conduct, LEARN MORE, Diversity and Inclusion Policy, DOWNLOAD, UK Modern Slavery Act statement 2024, DOWNLOAD, Access to Medicine, DOWNLOAD
,
Third Party Code of Conduct, DOWNLOAD
,
.image-container-logos {
display: flex;
justify-content: center;
align-items: center;
}
.image-container-logos img {
width: 70%;
,
setTimeout(boxStyling, 1000);
function boxStyling() {
jQuery('.paragraphs-item-picture-promo-list .field-collection-container .field-name-fi
/sustainability/esg-environmental
Environment, Environmental banner v3.png, Sustainability
,
.h2-environment-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
padding-top: 1em;
}
,
.text-image-container {
display: flex;
flex-direction: row;
align-items: center;
justify-content:
,
In order to reach our goal of 42% CO2 reduction by 2030, a number decarbonization levers are either planned or underway:
,
.circle-container {
display: flex;
gap: 40px;
flex-wrap: wrap;
align-items: center;
}
.circle {
padding: 15px;
width:
,
CO2 Reduction Roadmap.png
,
Progress on CO2 action planIn 2024, scope 1 and 2 emissions were 2% lower than the 2022 baseline, primarily due to reduced natural gas usage from repl
,
@media only screen and (min-width: 1024px){
.double-image {
display:flex;
gap:6%;
}
.double-image .second-image-green {
width:34%;
height:100%;
,
PollutionALK uses chemicals that fall within the scope of the Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) Regulation
,
.image-container-single-image-2 {
display: flex;
justify-content: center;
align-items: center;
height: 100%;
width: 100%;
,
Biodiversity and EcosystemsFrom farm to pharmaA majority of our allergen source materials are cultivated at our farm in Post Falls, Idaho, USA. Here,
,
Species Diversity, Minimize pesticide and fertilizer inputs, Protect native flora and fauna, Minumum soil disturbance
,
.image-container-single-image-3 {
display: flex;
justify-content: center;
align-items: center;
height: 100%;
width: 100%;
,
Partnering for sustainabilityThe challenges of climate change require commitments and partnerships
,
.image-container-logos {
display: flex;
justify-content: center;
align-items: center;
gap: 40px;
}
.image-container-logos .imag
/sustainability/esg-governance
Governance, Governance banner photo (1).jpg, Sustainability
,
.h2-sustainability-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
padding-top: 1em;
,
Whistleblowing protectionPromoting a culture of transparency and accountability, ALK encourages employees, suppliers, vendors, consultants or others w
,
ALK Alertline, Report concern, Code of Conduct, Learn more
,
.text-image-container {
display: flex;
flex-direction: row;
align-items: center;
justify-content:
,
Code of Conduct, DOWNLOAD, Anti-corruption Policy, LEARN MORE, Data Ethics Policy, DOWNLOAD, Third party code of conduct, DOWNLOAD
,
Tax policy, DOWNLOAD, Whistleblower Policy, DOWNLOAD, UK Modern Slavery Act statement 2024, DOWNLOAD
,
.image-container-logos {
display: flex;
justify-content: center;
align-items: center;
}
.image-container-logos img {
width: 70%;
,
setTimeout(boxStyling, 1000);
function boxStyling() {
jQuery('.paragraphs-item-picture-promo-list .field-collection-container .field-name-fi
/our-science/healthcare-professionals/clinical-trials
Healthcare professionals, Clinical trials, Clinical Trials moved position.png, OUR KEY SLIT TRIALS
,
a {
color: #002559;
}
.h3-clinical-trials-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h3-clinical-trials-alt-h
,
Our key SLIT-tablet randomised controlled trialsOur SLIT-tablets build on the legacy of subcutaneous immunotherapy, which was discovered in the early
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.clinical-trials-card-container {
display: flex;
gap: 40px;
justify-content: center;
max-width: 1200px;
margin: 10px auto 0 a
,
P05239Disease area: Allergic rhinoconjunctivitisPhase: IIIFollow-up: Single-seasonRegion: North AmericaAge group: Children and adolescentsNo. of parti
,
Tree SLIT-tabletTT-03Disease area: Allergic rhinoconjunctivitisPhase: IIFollow-up: 24 weeksRegion: Environmental exposure chamber (Europe)Age group: A
,
Ragweed SLIT-tabletP05233Disease area: Allergic rhinoconjunctivitisPhase: II/IIIFollow-up: One yearRegion: North AmericaAge group: AdultsNo. of partic
,
HDM SLIT-tabletMT-02Disease area: Allergic rhinoconjunctivitis and allergic asthmaPhase: II/IIIFollow-up: One yearRegion: EuropeAge group: Adolescents
,
P003Disease area: Allergic rhinoconjunctivitisPhase: IIFollow-up: Up to 76 weeksRegion: Environmental exposure chamber (Europe)Age group: AdultsNo. of
,
MT-12/MATICDisease area: Allergic rhinoconjunctivitisPhase: IIIFollow-up: One yearRegion: North America and EuropeAge group: ChildrenNo. of participan
,
Compliance with guidelinesIn compliance with industry guidelines, more information about all our clinical trials can be found via the freely public re
/our-science/healthcare-professionals/allergy-immunotherapy
Healthcare professionals, Allergy immunotherapy, Allergy-immunotherapy-banner.png
,
Targets the root cause of allergy by stimulating an immune responseAllergy immunotherapy (AIT) is the only treatment of allergic disease that addresse
,
Disease-modifying and protective effectTo achieve long-term sustained effect, where the benefits of the treatment continue after the treatment has end
,
Why has AIT disease-modifying effect?, <p><iframe src="https://www.alk.net/sites/default/files/2024-10/MoA%20AIT%20short%20video.mp4" frameborder="0" allowfulls, videoframe_5652.png, Watch video
,
.h3-bold-heading {
margin: 0;
font-weight: 600;
font-size: 35px;
color: #0a2455;
}
.clinical-trials-card-container {
displa
/terms-and-conditions/privacy-notice/shareholders-proxies-advisors
Privacy notice for shareholders, proxies and advisorsMarch 2025The purpose of this privacy notice is to describe how ALK-Abelló A/S (ALK), as part of , 1. Identity and contact details of the data controller, The legal entity responsible for processing you…
/our-solutions/emergency-medicine
Anaphylaxis, Treatment of acute allergic reactions, emergency_medicine_background_image.jpeg
,
Left, The recommended emergency treatment is an intra-muscular injection of adrenaline followed by an immediate call for medical assistance.ALK has develope, emergency_medicine_text_image.jpeg
,
Learn more about how we collect, extract and process venom from bees and wasps to create venom allergy treatments., ALK From Nature to Medicines_Short version 1080p-ENG.mp4, Watch the video
/terms-and-conditions/privacy-notice/crm-marketing
Privacy notice for CRM – MarketingJanuary 2025According to Article 12 of the General Data Protection Regulation, we must provide you with certain info, 1. Identify and contact details about the data controller, The data controller for the processing descr…
/terms-and-conditions/privacy-notice/job-application
Privacy notice related to your job application at ALKJanuary 2025As part of our recruitment process through EasyCruit, we are required to provide you , 1. Identify and contact details about the data controller, ALK, as the data controller, is responsible…
/terms-and-conditions/privacy-notice/newsletter
Privacy notice related to your subscription to our newsletterJanuary 2025The purpose of our website is to provide information about our company, produ, 1. Identify and contact details about the data controller, ALK, as the data controller, is responsible…